₹ 0.5 Cr
Volume Transacted
(Nov 22, 2024)
0.8 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 6336.9 | 6305.1 | 6421.15 | 6305.05 |
21 Nov 2024 | 6288.9 | 6588.95 | 6588.95 | 6222.35 |
19 Nov 2024 | 6497.5 | 6450.05 | 6588.35 | 6450.05 |
18 Nov 2024 | 6397.65 | 6792.05 | 6792.05 | 6362.75 |
14 Nov 2024 | 6770.6 | 7180 | 7180 | 6672.6 |
13 Nov 2024 | 7133.1 | 7392.55 | 7392.55 | 7100 |
12 Nov 2024 | 7410.5 | 7345 | 7777 | 7224.6 |
11 Nov 2024 | 7252.7 | 7315 | 7348.5 | 7218.05 |
08 Nov 2024 | 7317.65 | 7440.05 | 7543.05 | 7284.6 |
07 Nov 2024 | 7517 | 7764 | 7764 | 7505 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 6336.9 |
21 Nov 2024 | 6288.9 |
19 Nov 2024 | 6497.5 |
18 Nov 2024 | 6397.65 |
14 Nov 2024 | 6770.6 |
13 Nov 2024 | 7133.1 |
12 Nov 2024 | 7410.5 |
11 Nov 2024 | 7252.7 |
08 Nov 2024 | 7317.65 |
07 Nov 2024 | 7517 |
AstraZeneca Pharma gains on plan to launch COPD drug
Earlier, on 2 December 2023, the pharma company intimated about the receipt of import and ...
19 Nov 202412:11
AstraZeneca slumps as Q2 PAT slides 27% YoY to Rs 38 cr
Revenue from operations jumped 31.16% year on year (YoY) to Rs 408 crore in the quarter en...
14 Nov 202412:34
Astrazeneca Pharma India to announce Quarterly Result
Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...
25 Oct 202416:11
Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
Durvalumab (IMFINZI) in combination with chemotherapy as neoadjuvant treatment, followed b...
24 Sep 202408:54
Astrazeneca Pharma India Ltd leads gainers in 'A' group
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and Nation...
24 Sep 202412:00
Volumes spurt at Astrazeneca Pharma India Ltd counter
Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Schneider Electric Infrastructure Lt...
24 Sep 202414:30
Unlimited trading at just
Rs. 199*